Price (delayed)
$0.4579
Market cap
$7.04M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.38
Enterprise value
$1.99M
Organovo is an early-stage biotechnology company that is developing and utilizing highly customized 3D human tissues as dynamic models of healthy and diseased human biology for drug development. The company's
There are no recent dividends present for ONVO.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.